Published in PLoS Negl Trop Dis on March 21, 2013
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell (2015) 1.58
Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog (2015) 1.43
Viral arthritis. Clin Med (2016) 1.41
Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol (2013) 1.26
Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. PLoS Negl Trop Dis (2015) 1.24
Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol (2015) 1.19
Kinetics of chikungunya infections during an outbreak in Southern Thailand, 2008-2009. Am J Trop Med Hyg (2014) 1.06
Mayaro virus infection, Amazon Basin region, Peru, 2010-2013. Emerg Infect Dis (2013) 0.97
Animal Models of Chikungunya Virus Infection and Disease. J Infect Dis (2016) 0.96
Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand. Virol J (2014) 0.96
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe (2015) 0.95
A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol (2013) 0.92
The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015. Am J Trop Med Hyg (2016) 0.91
Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. J Virol (2014) 0.90
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest (2017) 0.89
Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection. PLoS Negl Trop Dis (2015) 0.89
Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis. Neurotherapeutics (2016) 0.89
Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients. PLoS Negl Trop Dis (2015) 0.88
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection. J Infect Dis (2015) 0.86
Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection. Vet Res (2016) 0.85
A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis. Open Rheumatol J (2016) 0.85
Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice. J Virol (2014) 0.84
The Global Virus Network: Challenging chikungunya. Antiviral Res (2015) 0.83
Prevalence of dengue and chikungunya virus infections in north-eastern Tanzania: a cross sectional study among participants presenting with malaria-like symptoms. BMC Infect Dis (2016) 0.83
Chikungunya Virus Infection: An Update on Joint Manifestations and Management. Rambam Maimonides Med J (2016) 0.82
Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity. PLoS Negl Trop Dis (2015) 0.82
Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity. Proc Natl Acad Sci U S A (2015) 0.81
Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex. Emerg Microbes Infect (2015) 0.79
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge. PLoS Negl Trop Dis (2014) 0.78
A Case of Diabetic Ketoacidosis Following Chikungunya Virus Infection. Am J Trop Med Hyg (2015) 0.78
Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model). Pathogens (2015) 0.78
Global emergence of Alphaviruses that cause arthritis in humans. Infect Ecol Epidemiol (2015) 0.78
Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells. PLoS Pathog (2015) 0.77
Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells. J Virol (2016) 0.77
Chikungunya fever in Canada: fever and polyarthritis in a returned traveller. CMAJ (2014) 0.77
Vector competence of Aedes aegypti in transmitting Chikungunya virus: effects and implications of extrinsic incubation temperature on dissemination and infection rates. Virol J (2016) 0.77
The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. Sci Rep (2016) 0.76
Chikungunya vaccines in development. Hum Vaccin Immunother (2016) 0.76
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence. Cell Rep (2016) 0.76
Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014. PLoS Negl Trop Dis (2016) 0.75
A large-scale stochastic spatiotemporal model for Aedes albopictus-borne chikungunya epidemiology. PLoS One (2017) 0.75
Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016. Emerg Infect Dis (2017) 0.75
The role of vitamin C in the treatment of pain: new insights. J Transl Med (2017) 0.75
Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection. Am J Trop Med Hyg (2017) 0.75
Immune-Mediated Protection and Pathogenesis of Chikungunya Virus. J Immunol (2016) 0.75
A chikungunya fever vaccine utilizing an insect-specific virus platform. Nat Med (2016) 0.75
Postchikungunya Chronic Inflammatory Rheumatism. Case Rep Rheumatol (2016) 0.75
Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen. Case Rep Urol (2015) 0.75
Ultrasound of ankles in the diagnosis of complications of chikungunya fever. Radiol Bras (2017) 0.75
Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? Future Microbiol (2016) 0.75
MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE. J Virol (2017) 0.75
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology. Mol Ther (2017) 0.75
The Range of Neurological Complications in Chikungunya Fever. Neurocrit Care (2017) 0.75
Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques. PLoS Negl Trop Dis (2017) 0.75
[Viral arthritis and vasculitis]. Z Rheumatol (2016) 0.75
Chikungunya Virus-Associated Disease. Curr Rheumatol Rep (2017) 0.75
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14
Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet (2007) 10.81
Chikungunya: a re-emerging virus. Lancet (2011) 3.73
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40
Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect (2008) 3.28
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest (2010) 2.92
Infectious diseases. Massive outbreak draws fresh attention to little-known virus. Science (2006) 2.90
Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis (2011) 2.69
Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol (2010) 2.64
Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med (2008) 2.49
Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis (2007) 2.44
Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J (1983) 2.38
Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis (2008) 2.31
Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med (2008) 2.21
Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16
Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis (2009) 1.87
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris) (2007) 1.83
Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol (2010) 1.60
Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. J Clin Microbiol (2005) 1.50
Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PLoS One (2009) 1.46
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis (2012) 1.42
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect (2011) 1.39
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis (2012) 1.36
Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One (2009) 1.29
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine (2009) 1.23
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol (2009) 1.22
Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness. BMC Infect Dis (2010) 1.18
Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J Gen Virol (1996) 1.16
Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect (2012) 1.16
Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract (2011) 1.08
Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med (2004) 1.07
Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology (Oxford) (2012) 1.06
Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther (2013) 1.05
Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in sri lanka, in 2007: a longitudinal cohort study. J Trop Med (2012) 0.96
Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology (2002) 0.93
Emerging viral infections and arthritis: the role of the rheumatologist. Nat Clin Pract Rheumatol (2007) 0.92
[Seroepidemiologic evaluation of malaria in Mayotte (Comoro archipelago) 1984-1988]. Bull Soc Pathol Exot (1990) 0.80
Viral arthritides. Expert Rev Anti Infect Ther (2011) 0.78
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med (2011) 7.13
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature (2011) 6.29
The Listeria transcriptional landscape from saprophytism to virulence. Nature (2009) 5.88
Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis (2007) 5.16
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
A new perspective on Listeria monocytogenes evolution. PLoS Pathog (2008) 3.85
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis (2005) 3.77
Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol (2010) 3.53
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40
Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe (2010) 3.39
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol (2002) 2.70
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis (2008) 2.61
Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis (2009) 2.54
Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med (2008) 2.49
A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci U S A (2007) 2.46
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest (2010) 2.43
Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis (2008) 2.31
Innate sensing of HIV-infected cells. PLoS Pathog (2011) 2.22
Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med (2008) 2.21
Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nat Med (2011) 2.14
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood (2006) 2.06
Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions. Trends Cell Biol (2003) 2.04
Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood (2009) 2.03
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood (2005) 2.01
Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature (2008) 1.90
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Visualizing the functional diversification of CD8+ T cell responses in lymph nodes. Immunity (2010) 1.85
Identification of the first human gyrovirus, a virus related to chicken anemia virus. J Virol (2011) 1.81
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. Blood (2010) 1.81
A molecular marker for evaluating the pathogenic potential of foodborne Listeria monocytogenes. J Infect Dis (2004) 1.78
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. EMBO J (2011) 1.74
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med (2005) 1.71
Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol (2011) 1.64
Worldwide distribution of major clones of Listeria monocytogenes. Emerg Infect Dis (2011) 1.64
Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. Clin Chem (2007) 1.58
Fungal infections in immunocompromised travelers. Clin Infect Dis (2012) 1.53
The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med (2010) 1.51
Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein. EMBO J (2005) 1.49
LPXTG protein InlJ, a newly identified internalin involved in Listeria monocytogenes virulence. Infect Immun (2005) 1.48
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med (2007) 1.48
Human listeriosis caused by Listeria ivanovii. Emerg Infect Dis (2010) 1.46
Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PLoS One (2009) 1.46
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med (2014) 1.45
Ocular adnexal lymphoma and Helicobacter pylori gastric infection. Am J Hematol (2010) 1.45
Chikungunya virus infection of corneal grafts. J Infect Dis (2012) 1.44
Healthcare-associated mucormycosis. Clin Infect Dis (2012) 1.42
Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38
The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res (2004) 1.37
Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med (2011) 1.36
Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis (2011) 1.36
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol (2005) 1.35
Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med (2012) 1.34
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults. Antimicrob Agents Chemother (2009) 1.34
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood (2003) 1.33
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis (2005) 1.31
Seasonality of human leptospirosis in Reunion Island (Indian Ocean) and its association with meteorological data. PLoS One (2011) 1.30
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. J Antimicrob Chemother (2010) 1.29
Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity. MBio (2014) 1.29
Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am (2010) 1.29
"Epidemic clones" of Listeria monocytogenes are widespread and ancient clonal groups. J Clin Microbiol (2013) 1.28
The ubiquitous nature of Listeria monocytogenes clones: a large-scale Multilocus Sequence Typing study. Environ Microbiol (2013) 1.27
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Immune response against dying tumor cells. Adv Immunol (2004) 1.26
Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med (2011) 1.24
Real-time observation of listeria monocytogenes-phagocyte interactions in living zebrafish larvae. Infect Immun (2009) 1.24
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. J Clin Microbiol (2011) 1.24
[Chikungunya virus: a reemerging alphavirus]. Med Sci (Paris) (2006) 1.22
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. J Infect Dis (2009) 1.22
Listeria rocourtiae sp. nov. Int J Syst Evol Microbiol (2009) 1.21
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med (2007) 1.20
Microbial strategies to target, cross or disrupt epithelia. Curr Opin Cell Biol (2005) 1.20
Switch to second-line ART in West African routine care: incidence and reasons for switching. AIDS Care (2011) 1.19
Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med (2007) 1.18
Species specificity of the Listeria monocytogenes InlB protein. Cell Microbiol (2006) 1.18
[Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women]. Presse Med (2006) 1.18
Similarities in Leptospira serogroup and species distribution in animals and humans in the Indian ocean island of Mayotte. Am J Trop Med Hyg (2012) 1.18
Src, cortactin and Arp2/3 complex are required for E-cadherin-mediated internalization of Listeria into cells. Cell Microbiol (2007) 1.16
Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat Rev Microbiol (2009) 1.16
Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog (2013) 1.15
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One (2010) 1.15
Melioidosis: an imported case from Madagascar. J Travel Med (2006) 1.14
Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerg Infect Dis (2013) 1.14
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol (2006) 1.13
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood (2006) 1.13